Search results for "RELATIONSHIP"

showing 10 items of 3616 documents

Treatment of acute rejection of cadaveric renal allografts with rabbit antithymocyte globulin.

1982

In a prospective randomized single-blind trial, we compared the effectiveness of rabbit antithymocyte globulin (RATG) in the treatment of acute renal graft rejection with the results of treatment by high oral doses of prednisone. Twenty recipients of cadaveric kidneys were included in each group. In the RATG group, the prednisone dose was not increased and a dose-by-rosette protocol was used to keep T cell levels between 50 and 150/mm3. In this group 15 of the 20 patients responded to the treatment. One of these patients lost her kidney afterward because of a technical failure. In five patients rejection was irreversible despite a subsequent course of high-dose prednisone orally. In the pre…

AdultGraft RejectionMaleTransplantationmedicine.medical_specialtyTime FactorsDose-Response Relationship Drugbusiness.industryT-LymphocytesRenal graftKidney TransplantationSurgeryRabbit antithymocyte globulinLeukocyte CountPrednisoneMedicineHumansPrednisoneFemaleProspective StudiesbusinessCadaveric spasmmedicine.drugAntilymphocyte SerumTransplantation
researchProduct

Treatment of Vaginal Trichomoniasis with a Single Dose of Tinidazole

1974

SummaryTwenty-two patients with proven vaginal trichomoniasis were treated with a single dose of 2 g. tinidazole. Twenty-one patients were cured, at both the early and the late follow-up visits. No side-effects were noted and no abnormalities of the clinical laboratory parameters were found in the trial. A historical comparison with published works was carried out and the results compared favourably with those found in the literature for tinidazole as well as for other agents used in a similar fashion.

AdultGynecologymedicine.medical_specialtyDose-Response Relationship Drugbusiness.industryVaginal trichomoniasisAdministration OralAntitrichomonal AgentsGeneral MedicineMiddle AgedTrichomonal VaginitisDermatologyTinidazoleAntitrichomonal agentchemistry.chemical_compoundchemistryNitroimidazolesmedicineHumansFemaleTrichomonas Vaginitisbusinessmedicine.drugCurrent Medical Research and Opinion
researchProduct

Effect of cordycepin on interleukin-10 production of human peripheral blood mononuclear cells

2002

Therapeutic options for controlling autoimmune diseases are still very limited. Interleukin-10 has been reported to be a promising approach to therapeutic intervention. In the search for a drug which results in the selective upregulation of interleukin-10, we investigated the immunoregulative effects of cordycepin. We have measured interleukin-10 and interleukin-2 secretion of human peripheral blood mononuclear cells that were incubated with cordycepin and assessed the influence of cordycepin on the expression of interleukin-10 mRNA, the proliferative response and the expression of surface markers on T lymphocytes. In addition, the subsets of interleukin-10-secreting cells, the influence of…

AdultInterleukin 2T-Lymphocytesmedicine.medical_treatmentPharmacologyBiologyLymphocyte ActivationPeripheral blood mononuclear cellchemistry.chemical_compoundAdjuvants ImmunologicAntigens CDmedicineHumansRNA MessengerIL-2 receptorCells CulturedPharmacologyDeoxyadenosinesDose-Response Relationship DrugCordycepinMonocyteInterleukinFlow CytometryInterleukin-10Up-RegulationInterleukin 10medicine.anatomical_structureCytokinechemistryImmunologyLeukocytes MononuclearInterleukin-2Cell Divisionmedicine.drugEuropean Journal of Pharmacology
researchProduct

Evidence that the interaction between circulating IgA and fibronectin is a normal process enhanced in primary IgA nephropathy

1991

A solid-phase ELISA was set up to measure the direct binding capacity (BC) of different, commercially available, purified human IgA preparations to plates coated with human fibronectin (FN). It was found that secretory, polymeric, and, to a much lesser extent, monomeric IgA exhibited elevated FN-BC as compared to their BC to plates coated with bovine serum albumin. This binding was specific since not observed with human IgG or IgM antibodies. In addition, we noted that this interaction was dose dependent, Ca2+ dependent, saturable, and not covalent, was inhibited by soluble FN, but not by a prior incubation of FN-coated plates with anti-human fibronectin antibodies, and appeared to involve …

AdultLiver CirrhosisMaleImmunoglobulin Amedicine.medical_specialtyHot TemperatureAdolescentImmunologyEnzyme-Linked Immunosorbent AssayAntigen-Antibody ComplexPathogenesisAntibody SpecificityInternal medicinemedicineHumansImmunology and AllergyBovine serum albuminEdetic AcidDose-Response Relationship DrugbiologyChemistryGlomerulonephritis IGAGlomerulonephritisMiddle Agedmedicine.diseaseFibronectinsFibronectinsImmunoglobulin AFibronectinDose–response relationshipEndocrinologyChromatography Gelbiology.proteinCalciumFemaleAntibody
researchProduct

Clinical Trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites.

2009

Summary Background  In patients with cirrhosis, ascites is defined as refractory when it cannot be mobilized or recurs early in standard diuretic therapy. Aim  To compare the safety and efficacy of intravenous high-dose furosemide + hypertonic saline solutions (HSS) with repeated paracentesis in patients with cirrhosis and refractory ascites. Patients and methods  Eighty-four subjects (59/25 M/F) with cirrhosis, mostly of viral aetiology, admitted for refractory ascites, were randomly assigned to receive furosemide (250–1000 mg/bid i.v.) plus HSS (150 mL H2O with NaCl 1.4–4.6% or 239–187 mEq/L) (60 patients, Group A) or to repeated paracentesis and a standard diuretic schedule (24 patients,…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosismedicine.medical_treatmentPilot ProjectsRefractoryFurosemideAscitesmedicineParacentesishypertonic saline solutionHumansParacentesisPharmacology (medical)DiureticsAgedAged 80 and overSaline Solution HypertonicRCT; hypertonic saline solution; ascitesHepatologymedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryGastroenterologyFurosemideAscitesMiddle Agedmedicine.diseaseHypertonic salineSurgeryTreatment OutcomeEffusionAnesthesiaFemaleDiureticmedicine.symptombusinessRCTmedicine.drugAlimentary pharmacologytherapeutics
researchProduct

Whole genome paired-end sequencing elucidates functional and phenotypic consequences of balanced chromosomal rearrangement in patients with developme…

2019

BackgroundBalanced chromosomal rearrangements associated with abnormal phenotype are rare events, but may be challenging for genetic counselling, since molecular characterisation of breakpoints is not performed routinely. We used next-generation sequencing to characterise breakpoints of balanced chromosomal rearrangements at the molecular level in patients with intellectual disability and/or congenital anomalies.MethodsBreakpoints were characterised by a paired-end low depth whole genome sequencing (WGS) strategy and validated by Sanger sequencing. Expression study of disrupted and neighbouring genes was performed by RT-qPCR from blood or lymphoblastoid cell line RNA.ResultsAmong the 55 pat…

AdultMale0301 basic medicineCandidate geneAdolescentDNA Copy Number VariationsDevelopmental Disabilities030105 genetics & heredityGenomeTranslocation GeneticStructural variationChromosome BreakpointsStructure-Activity RelationshipYoung Adult03 medical and health sciencessymbols.namesakeposition effectGeneticsHumansChildGeneGenetic Association StudiesGenetics (clinical)Paired-end tagComputingMilieux_MISCELLANEOUSchromosomal rearrangementsChromosome AberrationsGene RearrangementWhole genome sequencingGeneticsSanger sequencingwhole genome sequencingbiologystructural variationInfantNFIXPhenotype030104 developmental biology[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human geneticsintellectual disabilityChild Preschoolbiology.proteinsymbolsFemaleBiomarkers
researchProduct

Assessment of the cytotoxic potential of an aqueous-ethanolic extract from Thalassia testudinum angiosperm marine grown in the Caribbean Sea

2018

Abstract Objectives Reported antioxidant, anti-inflammatory and neuroprotective properties for one aqueous-ethanolic extract from Thalassia testudinum which grows in the Caribbean Sea compelled us to explore about extract cytotoxic effects. Methods Cell viability was assayed on tumour (HepG2, PC12, Caco-2 and 4T1) and non-tumour (VERO, 3T3, CHO, MCDK and BHK2) cell lines. The extract effects upon primary cultures of rat and human hepatocytes and human lymphocytes were assayed. Key findings The extract exhibited cytotoxicity against cancer cells compared to normal cells, and the IC50 values were 102 μg/ml for HepG2, 135 μg/ml for PC12, 165 μg/ml for Caco-2 and 129 μg/ml for 4T1 cells after 4…

AdultMale0301 basic medicineCell SurvivalDNA damagePrimary Cell CulturePharmaceutical ScienceHydrocharitaceaePC12 CellsRats Sprague-DawleyInhibitory Concentration 5003 medical and health sciencesNeoplasmsAnimalsHumansCytotoxic T cellLymphocytesViability assayCytotoxicityPharmacologyDose-Response Relationship DrugEthanolbiologyPlant ExtractsChemistryPharmacology. TherapyWaterHep G2 Cellsbiology.organism_classificationAntineoplastic Agents PhytogenicMolecular biologyRatsComet assay030104 developmental biologyCaribbean RegionCell cultureThalassia testudinumCancer cellSolventsCaco-2 CellsThalassia testudinum DNA damage cytotoxicity oxidative stressJournal of pharmacy and pharmacology
researchProduct

Metabolomic Changes after Coffee Consumption: New Paths on the Block

2021

Scope Several studies suggest that regular coffee consumption may help preventing chronic diseases, but the impact of daily intake and the contribution of coffee metabolites in disease prevention are still unclear. The present study aimed at evaluating whether and how different patterns of coffee intake (one cup of espresso coffee/day, three cups of espresso coffee/day, one cup of espresso coffee/day and two cocoa-based products containing coffee two times per day) might impact endogenous molecular pathways. Methods and results A three-arm, randomized, cross-over trial was performed in 21 healthy volunteers who consumed each treatment for one month. Urine samples were collected to perform u…

AdultMale0301 basic medicineEndocrinology Diabetes and MetabolismcoffeeEnergy metabolismMedicine (miscellaneous)030209 endocrinology & metabolismCoffee consumptionParallel computingUrine030204 cardiovascular system & hematologyBiology03 medical and health sciences0302 clinical medicineMetabolomicsArginine biosynthesisBlock (telecommunications)CaffeineCoffee intakeHumansxenobioticsFood scienceAmino AcidsMathematicsCacaoNutrition and Dietetics030109 nutrition & dieteticsDose-Response Relationship Drugmetabolomics3. Good healthMetabolic pathway030104 developmental biologycocoabiomarkerFemaleSteroidsDisease preventionCardiology and Cardiovascular Medicine[SDV.AEN]Life Sciences [q-bio]/Food and NutritionBiomarkersMetabolic Networks and PathwaysFood ScienceBiotechnology
researchProduct

A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancer

2021

Aim: To determine a recommended Phase II dose of the oral fluoropyrimidine trifluridine/tipiracil (FTD/TPI) combined with the multi-kinase inhibitor regorafenib (REG) in refractory metastatic colorectal cancer patients. Materials & methods: A conventional 3 + 3 dose finding design was used. FTD/TPI was administered on days 1–5 and 8–12 of a 28-day cycle, REG on days 2–22. Two dose levels were used: FTD/TPI 25 mg/m2 b.i.d. + REG 120 mg/d, then escalated to FTD/TPI 35 mg/m2 b.i.d. + REG 120 mg/d. Results: In total, 12 patients were treated at two dose levels. Three dose-limiting toxicities were observed; all were grade 3 hypertension causally attributed to REG. Recommended Phase II dose …

AdultMale0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyPyrrolidinesMaximum Tolerated DosePyridinesColorectal cancerAdministration OralTrifluridineDrug Administration ScheduleTrifluridine03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRefractoryRegorafenibInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineDose escalationHumansResponse Evaluation Criteria in Solid TumorsAgedTipiracilDose-Response Relationship Drugbusiness.industryPhenylurea CompoundsGeneral MedicineMiddle Agedmedicine.diseaseProgression-Free SurvivalDrug Combinations030104 developmental biologyOncologychemistryThird lineDrug Resistance Neoplasm030220 oncology & carcinogenesisHypertensionToxicityFeasibility StudiesFemaleColorectal NeoplasmsbusinessThyminemedicine.drugFuture Oncology
researchProduct

Group relationships in early and late sessions and improvement in interpersonal problems.

2016

Groups are more effective when positive bonds are established and interpersonal conflicts resolved in early sessions and work is accomplished in later sessions. Previous research has provided mixed support for this group development model. We performed a test of this theoretical perspective using group members' (actors) and aggregated group members' (partners) perceptions of positive bonding, positive working, and negative group relationships measured early and late in interpersonal growth groups. Participants were 325 Italian graduate students randomly (within semester) assigned to 1 of 16 interpersonal growth groups. Groups met for 9 weeks with experienced psychologists using Yalom and Le…

AdultMale050103 clinical psychologySocial Psychologymedicine.medical_treatmentPsycINFOInterpersonal communicationlaw.inventionConflict PsychologicalGroup psychotherapyYoung AdultInterpersonal relationshipRandomized controlled triallawSurveys and QuestionnairesSettore M-PSI/08 - Psicologia Clinicamental disordersmedicineHumansInterpersonal Relations0501 psychology and cognitive sciencesStudents05 social sciencesPerspective (graphical)General MedicineMiddle AgedAPIMObject AttachmentGroup ProcessesTraining groupTest (assessment)050106 general psychology & cognitive sciencesPsychiatry and Mental healthClinical PsychologyItalyGroup developmentInterpersonal problemGroup QuestionnaireFemalePsychologyGroup developmentClinical psychologyJournal of Counseling Psychology
researchProduct